We are live on !
Find out more
Globeflex Capital Portfolio holdings
AUM
$783M
Turnover
28.73%
1-Year Est. Return
81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
(+18%)
Cap. Flow
-$22.1M
Cap. Flow % of AUM
Cap. Flow %
-2.82%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$6.96M |
| 2 |
MYR Group
MYRG
|
+$4.57M |
| 3 |
Leonardo DRS
DRS
|
+$4.16M |
| 4 |
Semtech
SMTC
|
+$3.99M |
| 5 |
Everpure Inc
P
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Catalyst Pharmaceutical
CPRX
|
+$11.2M |
| 2 |
Credicorp
BAP
|
+$9.17M |
| 3 |
Nextpower Inc. Common Stock
NXT
|
+$6.93M |
| 4 |
XP
XP
|
+$6.54M |
| 5 |
Sterling Infrastructure
STRL
|
+$5.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.62% |
| 2 | Industrials | 20.44% |
| 3 | Financials | 17.73% |
| 4 | Healthcare | 17.14% |
| 5 | Consumer Discretionary | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Lockheed Martin
LMT
$139B
| $129K | 0.02% |
253
| – | – |
2019 Q2
28 quarters
|
|
352
Geron
GERN
$628M
| $128K | 0.02% |
+100,355
| New | +$141K |
2026 Q2
0 quarters
|
|
353
Clear Secure
YOU
$5.55B
| $128K | 0.02% |
+2,295
| New | +$125K |
2026 Q2
0 quarters
|
|
354
AtriCure
ATRC
$2.86B
| $126K | 0.02% |
4,496
| – | – |
2025 Q3
3 quarters
|
|
355
Morningstar
MORN
$9.15B
| $122K | 0.02% |
780
| – | – |
2026 Q1
1 quarter
|
|
356
Bowman Consulting
BWMN
| $121K | 0.02% |
+4,155
| New | +$131K |
2026 Q2
0 quarters
|
|
357
Magnolia Oil & Gas
MGY
$6.12B
| $121K | 0.02% |
+4,725
| New | +$135K |
2026 Q2
0 quarters
|
|
358
Paycom
PAYC
$10.7B
| $118K | 0.02% |
+938
| New | +$122K |
2026 Q2
0 quarters
|
|
359
Harmony Biosciences
HRMY
$1.97B
| $117K | 0.01% |
3,203
| – | – |
2024 Q3
7 quarters
|
|
360
Factset
FDS
$11.5B
| $115K | 0.01% |
499
| – | – |
2026 Q1
1 quarter
|
|
361
Chewy
CHWY
$9.19B
| $109K | 0.01% |
+5,535
| New | +$126K |
2026 Q2
0 quarters
|
|
362
Riley Exploration Permian
REPX
$913M
| $108K | 0.01% |
+3,282
| New | +$117K |
2026 Q2
0 quarters
|
|
363
Box
BOX
$5.84B
| $102K | 0.01% |
3,844
| – | – |
2021 Q4
18 quarters
|
|
364
Urban Outfitters
URBN
$7.45B
| $97.6K | 0.01% |
1,378
| – | – |
2025 Q2
4 quarters
|
|
365
Monarch Casino & Resort
MCRI
$1.94B
| $97.1K | 0.01% |
738
+70
| +10% | +$8.16K |
2022 Q4
14 quarters
|
|
366
Covista Inc
CVSA
$3.87B
| $95.1K | 0.01% |
763
| – | – |
2024 Q3
7 quarters
|
|
367
Salesforce
CRM
$176B
| $94K | 0.01% |
600
| – | – |
2023 Q2
12 quarters
|
|
368
Dycom Industries
DY
$6.6B
| $89.5K | 0.01% |
+177
| New | +$77.4K |
2026 Q2
0 quarters
|
|
369
OptimumBank Holdings
OPHC
$113M
| $89.1K | 0.01% |
15,253
+3,089
| +25% | +$17K |
2026 Q1
1 quarter
|
|
370
Merit Medical Systems
MMSI
$5.26B
| $87.2K | 0.01% |
1,257
| – | – |
2022 Q4
14 quarters
|
|
371
Viemed Healthcare
VMD
$340M
| $85.7K | 0.01% |
7,516
| – | – |
2024 Q4
6 quarters
|
|
372
BWX Technologies
BWXT
$11.6B
| $79.8K | 0.01% |
+410
| New | +$85.4K |
2026 Q2
0 quarters
|
|
373
Lantronix
LTRX
$206M
| $76.4K | 0.01% |
12,990
| – | – |
2025 Q3
3 quarters
|
|
374
Tetra Tech
TTEK
$10.4B
| $72.2K | 0.01% |
2,500
| – | – |
2023 Q1
13 quarters
|
|
375
Bumble
BMBL
$928M
| $70.4K | 0.01% |
22,000
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
QCM
Globeflex Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.
- Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
- Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
- Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
- Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
- Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
- Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
- Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.
Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.